Based on these findings, several studies have examined IL-1β signaling blockade for treatment of disc degeneration, with most focusing the inhibition of intracellular production or downstream effects on resident disc cells 12, 56. The gene discussed is IL1B; the disease is intervertebral disk degenerative disorder.